Page 2 - Adxn News Today

Addex Therapeutics Ltd (NASDAQ:ADXN – Free Report) saw a large drop in short interest during the month of June. As of June 15th, there was short interest totalling 226,300 shares, a drop of 40.4% from the May 31st total of 379,900 shares. Currently, 3.0% of the company’s shares are sold short. Based on an average […]

NEA Management Company LLC cut its stake in Addex Therapeutics Ltd (NASDAQ:ADXN – Get Rating) by 80.9% in the 4th quarter, HoldingsChannel reports. The fund owned 1,080,000 shares of the company’s stock after selling 4,568,690 shares during the period. NEA Management Company LLC owned 0.08% of Addex Therapeutics worth $113,000 at the end of the […]

GLOBAL health-oriented and wellness direct selling company DXN Holdings Bhd has been relisted on Bursa Malaysia’s main market on May 19, 2023 – on the heels of its recent announcement of profit after tax (PAT) of RM289.3mil for the financial year 2023 (FY23).

KUALA LUMPUR: Health-oriented and wellness direct-selling company DXN Holdings Bhd had a soft start as it made its return to the Main Market of Bursa Malaysia.

Addex Therapeutics Ltd (NASDAQ:ADXN – Get Rating) was the recipient of a large decline in short interest during the month of April. As of April 30th, there was short interest totalling 146,800 shares, a decline of 34.2% from the April 15th total of 223,100 shares. Based on an average daily volume of 379,400 shares, the […]

KUALA LUMPUR: DXN Holdings Bhd's initial public offering (IPO) was oversubscribed by 3.2 times by the Malaysian public, ahead of its return to the Main Market of Bursa Malaysia on May 19.

DXN Holdings Bhd, en route to a listing on the Main Market of Bursa Malaysia, is expected to see significant improvement in its revenue for the financial year 2023 (FY23).

Addex Therapeutics Ltd (NASDAQ:ADXN – Get Rating) was the target of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 223,100 shares, an increase of 195.9% from the March 31st total of 75,400 shares. Based on an average daily trading volume, of 430,900 shares, […]

Susquehanna International Group LLP purchased a new position in Addex Therapeutics Ltd (NASDAQ:ADXN – Get Rating) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 72,142 shares of the company’s stock, valued at approximately $45,000. Susquehanna International Group LLP owned 0.56% of Addex […]

KUALA LUMPUR: Main Market-bound DXN Holdings Bhd aims to raise about RM121.6mil from the public issue portion of its initial public offering (IPO), which will go towards the repayment of bank borrowings and working capital requirements.